Prostatic neoplasm
Clinical trials for Prostatic neoplasm explained in plain language.
Never miss a new study
Get alerted when new Prostatic neoplasm trials appear
Sign up with your email to follow new studies for Prostatic neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise in slowing advanced prostate cancer
Disease control CompletedThis study tested a combination of abiraterone acetate and prednisone in 131 men with advanced prostate cancer that had not yet spread on scans. The goal was to see if the drugs could lower PSA levels and delay cancer progression. Participants took daily pills alongside standard …
Matched conditions: PROSTATIC NEOPLASM
Phase 2 • Sponsor: Janssen Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New combo therapy aims to cut hormone treatment for prostate cancer
Disease control CompletedThis early-phase study tested a new approach for men with prostate cancer that has spread to nearby lymph nodes. The standard treatment combines radiation with 2-3 years of hormone therapy, which can cause lasting side effects. Researchers added a targeted radioactive drug (Lu-PS…
Matched conditions: PROSTATIC NEOPLASM
Phase 1 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Radioactive therapy shows promise for tough prostate cancer
Disease control CompletedThis phase 2 trial tested whether adding a radioactive drug (I-131-1095) to standard enzalutamide therapy helps men with a specific type of advanced prostate cancer that had worsened on another treatment. The study enrolled 120 men with PSMA-positive metastatic castration-resista…
Matched conditions: PROSTATIC NEOPLASM
Phase 2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Second-Chance radiation: new hope for recurrent prostate cancer?
Disease control CompletedThis early-phase study tested a highly targeted type of radiation (SBRT) in 17 men whose prostate cancer returned after prior radiation. The goal was to find the highest safe dose and see how well the body tolerated it. Participants received five focused treatments over two weeks…
Matched conditions: PROSTATIC NEOPLASM
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a fibre supplement slow prostate cancer? researchers ask patients first.
Knowledge-focused CompletedThis study explores whether men with early prostate cancer on active surveillance would be willing to take dietary fibre supplements, such as inulin or psyllium. Previous research hints these fibres may reduce inflammation and slow tumour growth, but no one has asked patients abo…
Matched conditions: PROSTATIC NEOPLASM
Sponsor: University of Aberdeen • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New EHR tool aims to boost Heart-Health talks for cancer survivors
Knowledge-focused CompletedThis study tested a tool built into electronic health records that prompts doctors to discuss heart health with cancer survivors during routine visits. Researchers enrolled 645 survivors of breast, prostate, colorectal, endometrial, and lymphoma cancers across 12 clinics. The goa…
Matched conditions: PROSTATIC NEOPLASM
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC